Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed
Blood
.
2001 May 15;97(10):3321-2.
doi: 10.1182/blood.v97.10.3321.
Authors
D P Steensma
,
L Letendre
,
A Tefferi
PMID:
11368066
DOI:
10.1182/blood.v97.10.3321
No abstract available
Publication types
Comment
Letter
MeSH terms
Clinical Trials as Topic*
Humans
Leukocyte Count*
Myelodysplastic Syndromes / blood
Myelodysplastic Syndromes / drug therapy*
Neutrophils*